Does maintenance and consolidative atezolizumab improve outcomes in patients with high risk NSCLC treated with SBRT?
Does weekly dosing of cisplatin compromise outcomes compared with every 3 weeks dosing in patients receiving chemoradiation for HNSCC?
Does structured exercise improve quality of life in patients on androgen deprivation therapy?
Answers
No, not in SWOG/NRG S1914 where there was no difference in OS and a higher rate of grade 3+ adverse events.
No. In the ConCERT trial, weekly cisplatin (40 mg/m2) had noninferior (actually better at 61% v 51%) locoregional control and the actual cumulative amount of cisplatin was slightly higher.
Yes, in STAMINA, 12 months of structured exercise resulted in superior quality of life outcomes. | QuadShot News
Does weekly dosing of cisplatin compromise outcomes compared with every 3 weeks dosing in patients receiving chemoradiation for HNSCC?
Does structured exercise improve quality of life in patients on androgen deprivation therapy?
Answers
No, not in SWOG/NRG S1914 where there was no difference in OS and a higher rate of grade 3+ adverse events.
No. In the ConCERT trial, weekly cisplatin (40 mg/m2) had noninferior (actually better at 61% v 51%) locoregional control and the actual cumulative amount of cisplatin was slightly higher.
Yes, in STAMINA, 12 months of structured exercise resulted in superior quality of life outcomes. | QuadShot News